Results
1
High return on equity, past performance and sound balance sheet.
1 companies
Genmab
Market Cap: DKK 123.6b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,007.00
7D
-2.0%
1Y
43.1%